Posted on November 4, 2010 by Albin Paul
Dr. Mehdi Khalid Vice President, Healthcare and Life Sciences Industry Business Unit Asia Paciﬁc and Japan at Oracle about key aspects of healthcare IT market in India & Oracle’s presence in this space.
DownloadHealth India 2010
Filed under: Health Sciences Global Business Unit, Healthcare IT, HSGBU, oracle, Oracle Health Sciences Global Business Unit | Tagged: health sciences global business unit, healthcare IT, HSGBU, oracle, Oracle Health Science Global Business Unit, Oracle Healthcare, Oracle HSGBU | Leave a comment »
Posted on September 30, 2010 by Albin Paul
The Institute is focused on research that will accelerate IT innovation to advance personalized medicine and the delivery of safe and effective treatments and health care services to patients around the globe. OHSI will work in tandem with academic research centers, focusing on a targeted set of research areas fundamental to the R&D and health care delivery challenges facing health sciences organizations today. Research priorities currently include: artificial intelligence and semantic technology; genomic, genetic and phenotypic data analysis; data mining to support optimization of clinical trials; and predictive algorithms and other technology to advance patient safety and provide advanced decision support at the point of care.Academic institutions interested in collaborating with OHSI in these focus areas should contact OHSI representatives at Oracle http://linkd.in/bXf98c
Oracle starts Oracle Health Sciences Institute (OHSI), in partnership with Sun Labs. This is exiting news and I hope we get to see the participation of Open Source Drug Development Network (OSDD) and initiative by CSIR India earlier supported by Sun Microsystems
Filed under: Drug Safety, genetic medicine, Online Data sharing, open access database, open source, oracle, Oracle Health Sciences Global Business Unit, Patient Safety, personalized medicine, Pharmacogenomics, pharmacovigilance | Tagged: Drug Safety, health sciences global business unit, HSGBU, OHSI, Open Source Drug Development Network, oracle, Oracle Health Science Global Business Unit, Oracle Health Sciences Institute, personalized medicine, Pharmacogenomics, pharmacovigilance, Sun Labs | 1 Comment »
Posted on August 23, 2009 by Albin Paul
The health ministry of India is planning to introduce e-governance for clinical trials in four years. The move will enable drug companies that
want to carry out clinical trials in India to register online from any part of the world. Once the required approval for conducting trials is obtained, the companies can also submit research data online to the country’s drug regulator Drug Controller General of India (DCGI), seeking marketing approval for their drug.
To maintain confidentiality, once the data is fed into the Software the software will split the information into components and no one individual would have an access to the complete information provided by a company.
“Confidentiality of the data submitted by companies would be taken care of,” the official added. The software will automatically send relevant data to various departments for clearances.
The drug regulator would deliver online approvals to companies after validating all the information submitted by companies. According to the official, it would take about four years to put the system in place and e-governance is expected to be implemented in the country by 2013.
The government also intends to make use of IT to discourage volunteers to enroll into more than one clinical trial resulting in adverse drug reactions. The government is using a finger printing software available through which clinical trial centres can be interlinked.
The drug regulator has also asked companies to install the software so that they can enroll first time volunteers and avoid drug reactions during trials.
Filed under: microarray | Tagged: Cliical informatics, Clinical IT, clinical research, Clinical Trial, clinical trial India, oracle, Oracle Health Science Global Business Unit | Leave a comment »